Viewing Study NCT02122068



Ignite Creation Date: 2024-05-06 @ 2:46 AM
Last Modification Date: 2024-10-26 @ 11:23 AM
Study NCT ID: NCT02122068
Status: COMPLETED
Last Update Posted: 2021-01-22
First Post: 2014-04-16

Brief Title: Meditation for Dementia Caregivers Major Depressive Disorder in Family Dementia Caregivers
Sponsor: University of California San Francisco
Organization: University of California San Francisco

Study Overview

Official Title: Mentalizing Imagery Therapy for Major Depressive Disorder in Family Dementia Caregivers
Status: COMPLETED
Status Verified Date: 2021-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Family dementia caregivers provide a needed service to relatives with dementia and to society but are often at risk for consequences to their own health such as depression reduced immune system function and burnout Mentalizing Imagery Therapy MIT previously known as Central Meditation and Imagery Therapy is a novel group mindfulness and guided imagery intervention designed to help caregivers reduce depressive symptoms and cope with the stress of caregiving We will conduct a pilot feasibility of MIT versus home relaxation practice with 24 dementia caregivers Half of the caregivers will be randomly assigned to receive a relaxation recording while the other half will receive MIT

To measure the effects of MIT we will obtain depression symptom ratings and questionnaires about psychological symptoms before and after MIT We will also study the biological effects of MIT We will do so by measuring brain activity recording the pulse in order to determine variation in beat to beat intervals of the heart and studying patterns of gene expression
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None